Nicolás Merchante

4.3k total citations
64 papers, 1.4k citations indexed

About

Nicolás Merchante is a scholar working on Hepatology, Epidemiology and Infectious Diseases. According to data from OpenAlex, Nicolás Merchante has authored 64 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 50 papers in Hepatology, 48 papers in Epidemiology and 17 papers in Infectious Diseases. Recurrent topics in Nicolás Merchante's work include Liver Disease Diagnosis and Treatment (44 papers), Hepatitis C virus research (44 papers) and Liver Disease and Transplantation (17 papers). Nicolás Merchante is often cited by papers focused on Liver Disease Diagnosis and Treatment (44 papers), Hepatitis C virus research (44 papers) and Liver Disease and Transplantation (17 papers). Nicolás Merchante collaborates with scholars based in Spain, United States and Chile. Nicolás Merchante's co-authors include Juan A. Pineda, Juan Macı́as, Antonio Rivero, José Antonio López Mira, Jesús Gómez‐Mateos, José Ángel García-García, Fernando Lozano, Antonio Rivero‐Juárez, Dolores Merino and Francisco Téllez and has published in prestigious journals such as PLoS ONE, Hepatology and Clinical Infectious Diseases.

In The Last Decade

Nicolás Merchante

64 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nicolás Merchante Spain 21 1.1k 980 406 181 89 64 1.4k
Dolores Merino Spain 19 955 0.9× 916 0.9× 348 0.9× 88 0.5× 98 1.1× 68 1.2k
Patrick Ingiliz Germany 24 1.5k 1.3× 1.4k 1.5× 384 0.9× 103 0.6× 71 0.8× 98 1.8k
Norbert Bräu United States 24 1.9k 1.7× 1.6k 1.6× 617 1.5× 147 0.8× 103 1.2× 68 2.2k
José Ángel García-García Spain 16 827 0.8× 826 0.8× 413 1.0× 207 1.1× 191 2.1× 35 1.3k
Elina Teicher France 19 527 0.5× 458 0.5× 459 1.1× 268 1.5× 168 1.9× 41 1.1k
Yvonne Higgins United States 15 611 0.6× 607 0.6× 255 0.6× 126 0.7× 83 0.9× 22 907
M Y Maïga Mali 14 431 0.4× 569 0.6× 263 0.6× 71 0.4× 99 1.1× 43 855
Abdurrahman Sagir Germany 14 547 0.5× 704 0.7× 179 0.4× 60 0.3× 91 1.0× 38 975
María Stella Mura Italy 16 230 0.2× 349 0.4× 394 1.0× 148 0.8× 169 1.9× 31 826
Pilar García‐Gascó Spain 15 439 0.4× 443 0.5× 418 1.0× 161 0.9× 267 3.0× 19 833

Countries citing papers authored by Nicolás Merchante

Since Specialization
Citations

This map shows the geographic impact of Nicolás Merchante's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nicolás Merchante with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nicolás Merchante more than expected).

Fields of papers citing papers by Nicolás Merchante

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nicolás Merchante. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nicolás Merchante. The network helps show where Nicolás Merchante may publish in the future.

Co-authorship network of co-authors of Nicolás Merchante

This figure shows the co-authorship network connecting the top 25 collaborators of Nicolás Merchante. A scholar is included among the top collaborators of Nicolás Merchante based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nicolás Merchante. Nicolás Merchante is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Merchante, Nicolás, et al.. (2022). Early Use of Sarilumab in Patients Hospitalized with COVID-19 Pneumonia and Features of Systemic Inflammation: the SARICOR Randomized Clinical Trial. idUS (Universidad de Sevilla). 25 indexed citations
3.
Merchante, Nicolás, Rocío Herrero, Pilar González-de-la-Aleja, et al.. (2022). Impact of COVID19 pandemic on the incidence of health-care associated Clostridioides difficile infection. Anaerobe. 75. 102579–102579. 9 indexed citations
5.
6.
Real, Luís Miguel, Juan Macı́as, Ana Belén Pérez, et al.. (2018). Baseline resistance-guided therapy does not enhance the response to interferon-free treatment of HCV infection in real life. Scientific Reports. 8(1). 14905–14905. 3 indexed citations
7.
Argüelles, Marcelo H., et al.. (2018). Rotavirus VP6 protein mucosally delivered by cell wall-derived particles from Lactococcus lactis induces protection against infection in a murine model. PLoS ONE. 13(9). e0203700–e0203700. 11 indexed citations
8.
Macı́as, Juan, Rafael Granados, Francisco Téllez, et al.. (2018). Similar recovery of liver function after response to all‐oral HCV therapy in patients with cirrhosis with and without HIV coinfection. Journal of Viral Hepatitis. 26(1). 16–24. 10 indexed citations
9.
Pineda, Juan A., Féderico García, Miguel García Deltoro, et al.. (2018). Executive summary: Consensus document of GEHEP of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC), along with SOCIDROGALCOHOL, SEPD and SOMAPA on hepatitis C virus infection management in drug users. Enfermedades Infecciosas y Microbiología Clínica. 38(3). 127–131. 9 indexed citations
10.
Merchante, Nicolás, Teresa Aldámiz‐Echevarría, Mónica García–Álvarez, et al.. (2017). Bacterial translocation and clinical progression of HCV‐related cirrhosis in HIV‐infected patients. Journal of Viral Hepatitis. 25(2). 180–186. 5 indexed citations
11.
Merchante, Nicolás, Sofía Ibarra, Boris Revollo, et al.. (2016). Real-life experience with sorafenib for the treatment of hepatocellular carcinoma in HIV-infected patients. AIDS. 31(1). 89–95. 12 indexed citations
12.
Pineda, Juan A., Rocío Núñez‐Torres, Francisco Téllez, et al.. (2015). Hepatitis C virus reinfection after sustained virological response in HIV-infected patients with chronic hepatitis C. Journal of Infection. 71(5). 571–577. 39 indexed citations
13.
Castro‐Iglesias, Ángeles, Antonio Rivero‐Juárez, Francisco Javier Martínez‐Marcos, et al.. (2015). Impact of HIV infection on sustained virological response to treatment against hepatitis C virus with pegylated interferon plus ribavirin. European Journal of Clinical Microbiology & Infectious Diseases. 34(10). 1929–1936. 8 indexed citations
14.
Pineda, Juan A., Celia Cifuentes, Manuel Parra, et al.. (2014). Incidence and natural history of hepatitis E virus coinfection among HIV-infected patients. AIDS. 28(13). 1931–1937. 44 indexed citations
15.
Merchante, Nicolás, Esperanza Merino, José López-Aldeguer, et al.. (2012). Increasing Incidence of Hepatocellular Carcinoma in HIV-Infected Patients in Spain. Clinical Infectious Diseases. 56(1). 143–150. 51 indexed citations
16.
Merchante, Nicolás, Luís F. López‐Cortés, Maria José Ríos-Villegas, et al.. (2011). Liver Toxicity of Antiretroviral Combinations Including Fosamprenavir Plus Ritonavir 1400/100 mg Once Daily in HIV/Hepatitis C Virus-Coinfected Patients. AIDS Patient Care and STDs. 25(7). 395–402. 7 indexed citations
17.
Neukam, Karin, María J. Vázquez, Celia Cifuentes, et al.. (2011). Efficacy of chronic hepatitis C therapy with pegylated interferon and ribavirin in patients on methadone maintenance treatment. European Journal of Clinical Microbiology & Infectious Diseases. 31(6). 1225–1232. 6 indexed citations
18.
Macı́as, Juan, José Ángel García-García, Nicolás Merchante, et al.. (2006). Low-level liver enzyme elevations during HAART are not associated with liver fibrosis progression among HIV/HCV-coinfected patients. Journal of Antimicrobial Chemotherapy. 59(1). 87–91. 4 indexed citations
19.
Macı́as, Juan, Miguel Á. Japón, Carmen Sáez, et al.. (2005). Increased Hepatocyte Fas Expression and Apoptosis in HIV and Hepatitis C Virus Coinfection. The Journal of Infectious Diseases. 192(9). 1566–1576. 33 indexed citations
20.
Macı́as, Juan, V. Castellano, Nicolás Merchante, et al.. (2004). Effect of antiretroviral drugs on liver fibrosis in HIV-infected patients with chronic hepatitis C. AIDS. 18(5). 767–774. 128 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026